BioLineRx (BLRX) Interest Coverage Ratio (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.57% |
| Sep 30, 2025 | -13.00% |
| Jun 30, 2025 | 46.57% |
| Mar 31, 2025 | 476.23% |
| Dec 31, 2024 | -70.20% |
| Sep 30, 2024 | 19.73% |
| Jun 30, 2024 | -46.66% |
| Mar 31, 2024 | 21.31% |
| Dec 31, 2023 | -71.02% |
| Sep 30, 2023 | 99.08% |
| Jun 30, 2023 | 152.76% |
| Mar 31, 2023 | -321.95% |
| Dec 31, 2022 | -76.11% |
| Sep 30, 2022 | 32.16% |
| Jun 30, 2022 | -38.63% |
| Mar 31, 2022 | 1.05% |
| Dec 31, 2021 | 35.78% |
| Sep 30, 2021 | -11.49% |
| Jun 30, 2021 | 47.68% |
| Mar 31, 2021 | 60.45% |
| Dec 31, 2020 | -26.22% |
| Sep 30, 2020 | 9.52% |
| Jun 30, 2020 | -14.93% |
| Mar 31, 2020 | 39.19% |
| Dec 31, 2019 | 6.68% |
| Sep 30, 2019 | -24.41% |
| Jun 30, 2019 | 17.96% |
| Mar 31, 2019 | -42.01% |
| Dec 31, 2018 | -96.19% |
| Sep 30, 2018 | 8.47% |
| Jun 30, 2018 | 1,517.91% |
| Mar 31, 2018 | -97.49% |
| Dec 31, 2017 | 8.94% |
| Sep 30, 2017 | -32.07% |
| Jun 30, 2017 | 95.96% |
| Mar 31, 2017 | 101.53% |
| Dec 31, 2016 | -60.93% |
| Sep 30, 2016 | 45.11% |
| Jun 30, 2016 | -18.09% |
| Mar 31, 2016 | 215.12% |
| Dec 31, 2015 | -2,171.05% |
| Sep 30, 2015 | -98.10% |
| Jun 30, 2015 | 718.37% |
| Mar 31, 2015 | 203.65% |
| Dec 31, 2014 | 523.88% |
| Sep 30, 2014 | 49.44% |
| Jun 30, 2014 | -82.13% |
| Mar 31, 2014 | 529.56% |
| Dec 31, 2013 | 34.97% |
| Sep 30, 2013 | -39.51% |
| Jun 30, 2013 | -16.33% |